5 Best Large-Cap Growth Stocks to Invest In Right Now

Large-cap companies are often well-established, profitable firms with long track records of delivering results for their customers and shareholders. Growth stocks are those considered by Wall Street to have above-average growth potential compared to their peers in the same industry or industrial sector. As an asset class, large-cap growth stocks offer relative stability, great capital appreciation potential and, in many cases, a good dividend income – all very attractive qualities to have in a long-term investment.

More conservative investors with a lower risk tolerance appreciate large-cap growth stocks because they can be less volatile compared to small- or mid-sized value stocks. All stocks fluctuate up and down with the market and other factors, but shares of large-cap growth companies are usually less vulnerable to dramatic price swings and big drawdowns.

Large, growing companies often do business worldwide. In that sense, many large-cap growth stocks offer investors global diversification regardless of where they're headquartered. An international presence can benefit shareholders by reducing risk through broad exposure to many countries in different regions of the world.

Many large-cap growth stocks are considered blue chips. They've been around for a long time, they have solid financials, strong revenue, good current and forward earnings, and decent dividends. With all of this in mind, here is a list of five high-quality, large-cap growth stocks to invest in today and hold for the future:

Johnson Controls International PLC (ticker: JCI)

Visa Inc. (V)

Walmart Inc. (WMT)

Microsoft Corp. (MSFT)

Apple Inc. (AAPL)

5 Best Large-Cap Growth Stocks to Invest: Johnson Controls International PLC (JCI)

JCI is a $44 billion company that makes standard and custom-designed building products and integrated building systems for customers in the U.S., Asia, Europe and several other regions around the world. The company may be best known for its heating, ventilation and air conditioning (HVAC) systems, but it's also quite prominent in security, fire detection, refrigeration and energy-efficiency systems.

One of the fastest growing and most interesting aspects of the company's business is what it calls its smart building solutions. It involves computer and cloud-based, data-driven hardware and software products commercial customers use to turn their properties into smart buildings. The products and services enhance the efficiency, comfort and safety of workspaces while making big improvements in the usability of existing systems.

In a recent research note, CFRA Equity Analyst Emily Nasseff Mitsch reiterated her "buy" rating on JCI. She noted healthy long-term sales growth and good prospects for smart and green building systems going forward.

JCI reported $3.50 in per-share earnings on $26.79 million in revenue for 2023. Nasseff Mitsch is estimating earnings of $3.56 per share and $28 million in revenue for 2024. The Wall Street consensus on JCI for 2024 is $3.61 in earnings and $27.8 million in revenue. The stock pays an annualized dividend of $1.48, which works out to a current yield of 2.3%.

5 Best Large-Cap Growth Stocks to Invest: Visa Inc. (V)

Visa is a large-cap growth stock with an impressive market capitalization that tops $551 billion. The company is very well known in the consumer credit card industry and is becoming predominant in payment processing as well. V has been able to maintain its long-term leadership status by developing and implementing cutting-edge financial technology, or fintech, that has kept it on the forefront of the financial transaction processing and reporting business.

The company can also be looked at as a fast-growing cybersecurity firm. In recent years, Visa has established itself as a global leader in digital fraud detection and mitigation technology.

Visa's revenue growth is truly impressive. Ten years ago, the company ended its 2014 fiscal year with $12.7 billion in revenue. For fiscal 2024, Wall Street estimates Visa will report $35.8 billion in revenue. If it hits that number, Visa will achieve 182% revenue growth over a decade.

V is not an income stock, but it will distribute $2.08 per share in dividends in 2024 for an annualized yield of 0.75%.

5 Best Large-Cap Growth Stocks to Invest: Walmart Inc. (WMT)

With more than 4,600 brick-and-mortar locations in the U.S. and a well-established and fast-growing e-commerce business, WMT is a retail powerhouse. In fact, considering that Wall Street estimates $673.4 billion in revenue for its current fiscal year of 2025, this $488 billion, 62-year-old company remains the largest retailer in the world when measured by total sales.

WMT has three divisions – Walmart U.S.A., Walmart International and Sam's Club – and all of them are booming. It operates large supercenter stores that all include thousands of items for sale and a full inventory of fresh and packaged groceries, smaller stores they call Walmart Neighborhood Markets and big box, member-only warehouse clubs that compete head-to-head with Costco Wholesale Corp. (COST) locations.

Year to date, WMT stock has appreciated about 13.8% and pays a current dividend of 83 cents a year, giving it a 12-month yield of 1.37%.

Morgan Stanley has an "overweight" rating on WMT, while CFRA maintains a "buy" rating and RBC Capital rates the stock "outperform."

5 Best Large-Cap Growth Stocks to Invest: Microsoft Corp. (MSFT)

Microsoft has a market cap of more than $3 trillion, making it more than a large-cap growth stock; it's a mega-cap growth stock. MSFT is one of the largest and best known technology companies in the world. It offers a wide variety of software, hardware components, gaming systems and cloud computing services for individuals and institutions worldwide. In addition to its ubiquitous Office Suite products, MSFT is the preeminent player in computer operating systems.

Brad Sills and Adam Bergere cover MSFT for Morgan Stanley Equity research. In their latest research report on April 1, they maintained their "buy" rating on the stock and reiterated their $480 12-month price target. If the stock hits that target, current shareholders will enjoy 12.6% upside from here.

As the rational for their optimistic opinion, Sills and Bergere cited that MSFT is positioned very well for sustained growth over the next three to five years. They were especially impressed with the long-term potential of the firm's Azure cloud infrastructure platform and growth in the gaming segment.

Income investors will appreciate that MSFT has raised its annual dividend every year for 22 consecutive years. The current annualized dividend is $3.00, which equates to a 0.71% yield.

5 Best Large-Cap Growth Stocks to Invest: Apple Inc. (AAPL)

AAPL is one of the most widely held stocks in the world, and it's no wonder that it shores up this list.

An undisputed technology giant with a market cap of more than $2.6 trillion, Wall Street estimates that AAPL will generate $387.2 billion in revenue and report $6.55 in earnings per share for 2024. Next year, analysts expect even more from the company. The 2025 revenue estimate is a staggering $411.9 billion, with earnings projected at $7.15. These are lofty figures that will be difficult to achieve, but if AAPL does deliver, it would mean 6.3% top-line and 9.1% bottom-line one-year growth. That would be extraordinary for such a large company.

AAPL has been a consistent large-cap growth stock performer for much of the 21st century. The company achieved this by generating unprecedented levels of brand loyalty among its many millions of customers around the world. This and its commitment to developing new and innovative products should fuel growth well into the future.

According to the company's latest round of financial reports released in December 2023, AAPL had more than $73 billion in cash on hand at the close of 2023. Some of that cash is earmarked to fund the company's aggressive stock buyback program, which should support the stock price going forward.

Top 3 Favorite Stocks to Buy Right Now in 2024

Many investors have a list of stocks they are keeping their eye on. Some might be stocks already in the portfolio that could be added to, and others could be stocks to keep an eye on as future portfolio additions. Keeping track of potential stock buys can help investors make more informed decisions, and keep an eye on any important news.

Here are three stocks that I think are a buy right now, and that should be on any investor's list of potential investments. Each has strong historical results and a bright future. Let's dig in to see what has these companies at the top of my list.

Top 3 Favorite Stocks to Buy Right Now: Costco

If you've ever had the experience of navigating a crowded Costco Wholesale (NASDAQ: COST) parking lot just to get into the store, you've experienced why the company has grown to be the third-largest retailer in the world. Costco's membership fee business model was unique when it began, but it has been a driver of the company's results for decades. In the last 12 months, Costco brought in nearly $5 billion in membership fees.

Costco has also proven to be resilient to slowing economic conditions. While we may not be in a recession, inflation has led to people pulling back on spending, if only a little. To the extent that's the case, Costco has not felt it. In its fiscal second quarter, which ended in February, Costco reported same-store sales growth of 5.6% and an increase of 5.3% in traffic. Costco's value proposition is clear to its members, who renew at a rate of over 90%.

Top 3 Favorite Stocks to Buy Right Now: Amazon

For those not paying attention to Amazon's (NASDAQ: AMZN) stock over the past few years, it may come as a surprise that in 2022 it traded for its lowest price since early 2019. This was due to substantial operating losses in its e-commerce business because of the spending on its distribution footprint necessary to meet pandemic-fueled demand. Over the past year, the improvement has been impressive.

In fourth-quarter 2022, Amazon reported an operating loss of $240 million in its North America segment (which is essentially the e-commerce business in North America) and an operating loss of $2.2 billion in its International segment (which is essentially the e-commerce business outside of North America). In Q4 2023, these improved to an operating income of $6.6 billion in North America and an operating loss of $419 million in the International segment.

These figures are a result of a concerted effort to rightsize the business coming out of the pandemic's height. This improvement in operating results led to net income improving by more than $10 billion and free cash flow increasing by nearly $50 billion.

Top 3 Favorite Stocks to Buy Right Now: Coupang

If you read about Korean e-commerce giant Coupang (NYSE: CPNG), you'd be forgiven for assuming you were reading about Amazon instead. Taking a play directly out of the Amazon playbook, Coupang has grown to be a formidable player for e-commerce on the Korean peninsula and has recently expanded abroad, most notably into Taiwan.

In Q4 2023, Coupang reported that its active customers grew 16% year over year to 21 million. Much like Amazon's Prime offering, Coupang has a membership program called Rocket WOW that includes free shipping, free returns, and dawn and same-day delivery. Growth in WOW members was 27% in Q4, outpacing overall membership growth and demonstrating the popularity and value proposition of the Rocket WOW program.

Coupang is also starting to see economies of scale as it grows. In Q4 2023, operating income was $473 million, a substantial improvement from the $112 million operating loss posted in Q4 2022. Free cash flow followed a similar trajectory, growing by approximately $2 billion year over year.

Should you invest $1,000 in Costco Wholesale right now?

Before you buy stock in Costco Wholesale, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Costco Wholesale wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $537,557!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

10 Cheap Dividend-Growth Stocks to Buy in2024

Dividend-growth stocks—those companies with a history of steady and increasing dividends over time—have lagged the broader market lately: The  US Dividend Growth Index has underperformed the  US Market Index by 14 full percentage points over the trailing one-year period.

Why the dramatic underperformance of dividend-growth stocks? Blame the narrow, tecnology-led stock market during much of that time, says Dan Lefkovitz, a strategist with  Indexes. “Dividend-payers may lag during market environments led by hot growth stocks, but in down periods like 2022 and 2018, they show resilience,” he observes.

Dividend-growth stocks have three things going for them today:

  • Companies with growing dividends tend to be profitable and financially healthy, two valuable qualities during periods of economic uncertainty.
  • Such companies are also more likely to have competitive advantages that may allow them to pass along price increases and thereby maintain margins during inflationary times.
  • Dividend-growth stocks tend to be less volatile than the overall stock market and are therefore attractive investments for playing a little defense.

To uncover some cheap dividend-growth stocks to investigate further, we’re turning to the  US Dividend Growth Index.

10 Cheap Dividend-Growth Stocks to Buy

These stocks from the  US Dividend Growth Index have increased their dividend payments over the past five years, pay out no more than 75% of their earnings in the form of dividends, possess competitive advantages (as measured by the  Economic Moat Rating), and were trading at among the widest discounts to our fair value estimates as of March 1, 2024.

Albemarle ALB
FMC Corp. FMC
Sirius XM Holdings SIRI
Lithia Motors LAD
Baxter International BAX
Polaris PII
ResMed RMD
Comerica CMA
Eastman Chemical EMN
Humana HUM

Here’s a little bit from  analysts about each of the stocks from the list. All data is as of March 1, 2024.

Albemarle

  • Price/Fair Value: 0.48
  •  Economic Moat Rating: Narrow
  • Forward Yield: 1.12%
  •  Capital Allocation Rating: Standard
  • Industry: Specialty Chemicals

Albemarle tops our list of cheap dividend-growth stocks—but its forward yield is among the lowest on our list, serving as a reminder that dividend-growth stocks aren’t necessarily high-yielding stocks. One of ’s top lithium picks, Albemarle is among our analysts’ favorite 33 undervalued stocks for the first quarter.  strategist Seth Goldstein expects lithium demand to more than triple by 2030, providing Albemarle with solid dividend growth potential ahead; we forecast earnings to average around 30% of net income over the next five years. In early March, the company announced a surprise plan to issue convertible preferred shares; depending on the terms of the offering, which have yet to be announced as of this writing, we may adjust our fair value estimate. Albemarle stock trades 52% below our current $300 fair value estimate.

FMC Corp

  • Price/Fair Value: 0.52
  •  Economic Moat Rating: Narrow
  • Forward Yield: 4.05%
  •  Capital Allocation Rating: Standard
  • Industry: Agricultural Inputs

The first of three new names on our list of cheap dividend-growth stocks to buy, FMC is a pure-play crop chemical producer. FMC is also among our analysts’ top 33 undervalued stocks for the first quarter. While we think that the firm’s distributions are appropriate and that the company will generate sufficient cash flows to maintain its dividend, FMC faces cyclicality risk and as a result is carrying elevated leverage on the books as chemical crop demand approaches its cyclical bottom, explains ’s Goldstein. We think this dividend-growth stock looks attractive as it trades 48% below our $110 fair value estimate.

Sirius XM Holdings

  • Price/Fair Value: 0.57
  •  Economic Moat Rating: Narrow
  • Forward Yield: 2.49%
  •  Capital Allocation Rating: Exemplary
  • Industry: Entertainment

Also new to our list of undervalued dividend-growth stocks, Sirius XM trades 57% below our fair value estimate of $7.50. Warren Buffett’s Berkshire Hathaway recently increased its position in the dividend stock. The company consists of two businesses: SiriusXM and Pandora. Sirius XM management prioritizes shareholder returns, says  senior analyst Matthew Dolgin; the firm earns an Exemplary capital allocation rating. While its board issued a special dividend in 2022 because of company outperformance in 2021, we don’t expect another special dividend anytime soon, adds Dolgin.

Lithia Motors

  • Price/Fair Value: 0.60
  •  Economic Moat Rating: Narrow
  • Forward Yield: 0.67%
  •  Capital Allocation Rating: Standard
  • Industry: Auto and Truck Dealerships

Lithia Motors sells new and used vehicles and provides related services, often in rural markets where there are no competitors within 100 miles. This rural focus gives Lithia pricing power and contributes to its economic moat, says  strategist David Whiston. Whiston calls the balance sheet “healthy” and commends the firm for raising its dividend in 2020 despite the coronavirus pandemic. We view Lithia’s growth runway as excellent; in fact, Whiston calls Lithia “the most exciting growth story in our auto dealer coverage.” This cheap dividend-growth stock trades 40% below our $500 fair value estimate.

Baxter International

  • Price/Fair Value: 0.61
  •  Economic Moat Rating: Narrow
  • Forward Yield: 2.83%
  •  Capital Allocation Rating: Standard
  • Industry: Medical Instruments and Supplies

Of the dividend-growth stocks on our list, Baxter International may require a longer-term mindset than some others. True, the firm can claim top-tier positions in most of its product lines and benefits from switching costs, which underpin its narrow moat rating. However, supply chain disruptions and economic uncertainty stalled Baxter in 2022 more so than some of its peers, observes  senior analyst Julie Utterback. Perhaps more troubling for dividend-growth aficionados, the company will slow the growth of its dividend as it integrates the Hillrom deal, which negatively affected its net leverage. That being said, Utterback expects Baxter to resume growing its dividend in line with earnings once the firm hits its leverage target, and we think the stock looks cheap, trading 39% below our $67 fair value estimate.

Polaris

  • Price/Fair Value: 0.64
  •  Economic Moat Rating: Wide
  • Forward Yield: 2.82%
  •  Capital Allocation Rating: Exemplary
  • Industry: Recreational Vehicles

Polaris is one of the longest-operating brands in powersports.  senior analyst Jaime Katz notes that fourth-quarter earnings disappointed and the company’s forecast for 2024 is plagued by slowing industrywide demand. We nevertheless expect Polaris to produce strong cumulative cash flow over the next five years and to continue to grow its dividend, averaging a 33% payout ratio over the next decade, she adds. This dividend-growth stock to buy trades 36% below our $145 fair value estimate.

ResMed

  • Price/Fair Value: 0.68
  •  Economic Moat Rating: Narrow
  • Forward Yield: 1.10%
  •  Capital Allocation Rating: Exemplary
  • Industry: Medical Instruments & Supplies

ResMed is one of two leading players in the global obstructive sleep apnea market, and we see plenty of global growth opportunity ahead, says  analyst Shane Ponraj. The firm is in a strong financial position, and while shareholder distributions might seem low (averaging 38% of underlying net income over the past five years), we think the level is appropriate, given that the company has instead chosen to spend more on strategic acquisitions that take advantage of trends in digital health in the home-care setting, concludes Ponraj. The stock looks cheap to us as it trades 32% below our $258 fair value estimate.

Comerica

  • Price/Fair Value: 0.68
  •  Economic Moat Rating: Narrow
  • Forward Yield: 5.73%
  •  Capital Allocation Rating: Standard
  • Industry: Banks—Regional

Comerica is the highest-yielding stock on our list of cheap dividend-growth stocks to buy. Comerica is largely a commercial-focused bank, with more than 90% of loans related to commercial lending, reports  analyst Rajiv Bhatia. Fourth-quarter results were decent on the surface, but we forecast profitability to worsen over the short term as net interest income continues to decline and expenses trend higher; we expect the pattern to flatten in 2024. We still expect the bank to remain profitable and to easily cover its dividend, says Bhatia. We currently assign a $73 fair value estimate to this dividend-growth stock; it’s trading 32% below that.

Eastman Chemical

  • Price/Fair Value: 0.70
  •  Economic Moat Rating: Narrow
  • Forward Yield: 3.72%
  •  Capital Allocation Rating: Standard
  • Industry: Specialty Chemicals

Eastman Chemical stock is about 30% undervalued relative to our $125 fair value estimate. The global specialty chemicals company generates most of its sales outside of the US. Although Eastman reported companywide volume declines year over year during the latest quarter, we expect 2024 will show a gradual recovery, says ’s Goldstein. The company generates strong cash flows and should therefore have no trouble meeting its dividend, he adds. Notably, management’s compensation is tied to return on capital and return to stockholders.

Humana

  • Price/Fair Value: 0.70
  •  Economic Moat Rating: Narrow
  • Forward Yield: 1.01%
  •  Capital Allocation Rating: Standard
  • Industry: Healthcare Plan

The final new name on our list of cheap dividend-growth stocks to buy—and the final name on the list altogether—is Humana. Humana stock is trading 30% below our fair value estimate. Management’s outlook for 2024 and 2025 came out weaker than we expected, particularly the company’s core end market of Medicare Advantage, admits ’s Utterback. The firm nevertheless maintains a strong franchise and remains at the forefront of one of the fastest-growing areas in US medical insurance. She calls the company’s dividend rate “modest” and notes that the dividend should be maintained despite weakness in near-term profit prospects. We think this dividend-growth stock is worth $500 per share.

Dividend-Growth Stocks and Economic Moats

 thinks that companies with economic moats have significant advantages that allow them to successfully fend off competitors for decades. Such high-quality companies can carve out their moats in a variety of different ways—by having high switching costs, through strong brand identities, or by possessing economies of scale, to name just a few.

Companies that we think can maintain their competitive advantages for at least 10 years earn narrow moat ratings; those we think can successfully compete for 20 years or longer earn wide moat ratings.

Of course, companies that do not have economic moats can exhibit dividend growth. But for purposes of this article, we included only stocks that have narrow or wide moat ratings, choosing to place our bets with high-quality companies.

Cheap Dividend-Growth Stocks: More Ideas to Consider

Investors who would like to find more undervalued dividend-growth stocks to research further can do the following:

  • Review the full list of stocks included in the  US Dividend Growth Index. Those dividend stocks with  Ratings of 4- or 5-stars are undervalued according to our metrics.
  • Peek into the portfolios of some of the best dividend-growth-stock managers for new ideas. Some highly rated funds focused on dividend-growth stocks include Vanguard Dividend Growth VDIGX and T. Rowe Price Dividend Growth PRDGX.
  • Use  Investor to build a watchlist of dividend growth stocks and create a view that allows you to easily follow the valuations, ratings, and dividend yields of the stocks on your list.

The 5 Best Stocks 2024

 Buying stocks can be straightforward, but identifying the right ones without a solid strategy is challenging. Wondering which stocks to buy or add to your watchlist? Consider Microsoft (MSFT), Ares Management (ARES), Dexcom (DXCM), Square's parent company Block (SQ), and Shockwave Medical (SWAV) as top contenders.

Inflation concerns and aggressive Federal Reserve rate tightening unsettled investors last year. However, the market defied expectations and delivered impressive results in 2023. While 2024 forecasts suggest more moderate gains, there's growing confidence in the Fed's ability to achieve a soft landing.

Key Ingredients for Selecting the Best Stocks

With thousands of stocks traded on the NYSE and Nasdaq, pinpointing the best ones is crucial for significant gains. The CAN SLIM system provides clear guidelines for identifying potential winners. Focus on stocks with recent quarterly and annual earnings growth of at least 25%. Look for companies introducing innovative products or services, including newly public companies showing substantial revenue growth.

CAN SLIM consistently outperforms the S&P 500, emphasizing the importance of surpassing industry benchmarks for exceptional long-term returns. Additionally, monitor stock supply and demand, prioritize leading stocks in top industry groups, and seek stocks with robust institutional support.

After identifying suitable stocks, analyze stock charts to determine optimal entry points. Wait for stocks to form a base and buy once they reach a buy point, preferably with heavy volume. Keep a close eye on market trends, and invest during confirmed uptrends while moving to cash during corrections.

Top Stocks to Watch and Buy

Amid a confirmed uptrend in the stock market, investing in high-quality stocks is advisable. The following selections represent some of the best stocks to consider:

  • Microsoft
  • Ares Management
  • Dexcom
  • Block
  • Shockwave Medical

These stocks exhibit impressive relative strength and warrant closer examination.

Microsoft Stock Analysis

Microsoft has demonstrated notable performance, rebounding from the 10-week moving average and achieving a short consolidation. Key indicators, such as EPS growth and institutional interest, signal strong potential for continued success.

Ares Management Stock Analysis

Ares Management shows promising signs with a flat base formation and robust earnings performance. Despite industry challenges, the firm's diversified portfolio and substantial assets under management position it for continued growth.

Dexcom Stock Analysis

Dexcom's innovative glucose monitoring systems and solid financial performance make it a compelling investment option. The company's expansion into new markets and recent product approvals further enhance its growth prospects.

Block Stock Analysis

Block's success in digital payments and strategic acquisitions, such as Afterpay, underscores its growth trajectory. Strong earnings and revenue growth projections support its bullish outlook.

Shockwave Medical Stock Analysis

Despite recent setbacks, Shockwave Medical's pioneering technology and rebounding performance indicate potential for recovery. With favorable reimbursement trends and growing institutional interest, the company is poised for future growth.

Market Outlook and Conclusion

As the stock market continues its upward trajectory, investors should remain vigilant for potential sell signals. Implementing disciplined risk management practices, such as adhering to predetermined stop-loss levels, is essential to mitigate losses and protect gains.

While the current market environment appears favorable, external factors such as inflation and geopolitical tensions can introduce volatility. Stay informed and adapt investment strategies accordingly to navigate market uncertainties effectively.

In summary, by focusing on high-quality stocks with strong fundamentals and adhering to proven investment principles, investors can capitalize on market opportunities and achieve long-term financial success.

Top 5 Blue-Chip Stocks To Buy for February in 2012

These top five stocks for February have the immediate growth potential and are seeing exceptional buying pressure. I want to make certain you’re not missing out on these wonderful opportunities.
Two of the top five stocks for February are returning veterans from January and other months, but I’ve added some new stocks as well. Let’s get started:

Alexion Pharmaceuticals

Top 5 Blue-Chip Stocks To Buy for February in 2012 - Alexion (NASDAQ:ALXN) remains the No. 1 stock on my buy list. This stock has been surging higher in recent weeks, and shares responded very positively to the news that the company is expanding its product portfolio through its $1 billion bid for Enobia Pharma, a developer of therapies for serious genetic bone disorders. The company currently is working to get its hypophosphatasia treatment, asfotase alfa, approved in the United States. To date, there is no approved treatment for this life-threatening disease. So, if approved, the company would have a tremendous first-mover advantage. Alexion, who will acquire full worldwide development and commercial rights to asfotase alfa, is confident the drug can obtain approval. Analysts currently expect Alexion to grow sales by 41.4% and earnings by 30.8% in the fourth quarter. ALXN reports Thursday, Feb. 9.
AutoZone
Top 5 Blue-Chip Stocks To Buy for February in 2012 - AutoZone (NYSE:AZO) has taken off on its next leg higher because it is the perfect stock for the current automobile market. Although consumers are buying new cars when necessary, they also are extending the lives of those vehicles and getting as much mileage as they can for their buck. And companies like AutoZone do this superbly by supplying the parts to keep well-worn cars in top condition. Looking forward to the company’s next quarterly earnings report, expected in late February, analysts currently estimate AutoZone will announce 7% growth in sales and 19.8% growth in earnings. The stock should be a solid performer in the coming weeks. AZO is a strong buy.

Dollar Tree

Top 5 Blue-Chip Stocks To Buy for February in 2012 - Dollar Tree (NASDAQ:DLTR) knows one of the best ways of coping with thinning wallets is to stretch each and every dollar. So, while lean times hit other retailers particularly hard, Dollar Tree stores flourished. The company is the largest and most successful single-price-point retailer in the U.S. — everything in its 4,000 locations is just $1. The company has continued its success even as the U.S. economy improves, and I don’t believe the desire of consumers to save money will be disappearing anytime in 2012. In fact, analysts currently expect the company to report 11.5% sales growth and 22.5% earnings growth in its Feb. 22 earnings announcement.

McDonald’s

Top 5 Blue-Chip Stocks To Buy for February in 2012 - McDonald’s (NYSE:MCD) is the world’s No. 1 fast-food company and a solid winner for this buy list. Analysts expected the company to report 9.1% sales growth and 11.2% earnings growth this week. McDonald’s answered back by beating earnings expectations for 14th time in the past 16 quarters. Although this did not push the stock higher, I still believe the positive earnings report will be a catalyst for further gains. McDonald’s plans to invest in store expansions around the globe in 2012, with two-thirds of its new stores to be located in Asia.
Ross Stores
Top 5 Blue-Chip Stocks To Buy for February in 2012 - Ross Stores (NASDAQ:ROST) is the nation’s largest off-price apparel and home fashion retailer and continues to benefit from value-focused customers. The stock has been a solid performer so far in the new year. In December, ROST reported that its same-store sales jumped 9.2%, over double the 4% estimate! I’m looking forward to the company’s Q4 earnings announcement and finding out how these exceptional sales affected the company’s earnings. Analysts are currently expect the company to report 10.9% sales growth and 20.3% earnings growth, and a solid surprise could be just the ticket to the stock’s next leg higher.

5 $200-Plus Stocks Worth Every Cent to invest in 2013

There are some low-priced stocks out there that really catch Wall Street’s fancy. There’s some kind of love affair with a cheap stock — with investors fooling themselves into thinking that it’s easier for a $1 stock to get to $2 than it is for a $100 stock to get to $200.
But the bottom line is still the bottom line. A stock succeeds or fails on the merit of its business, not logistical nonsense like shares outstanding or the headline value of stock.
Take the 50-to-1 stock split that Berkshire Hathaway (NYSE:BRK.B) executed in 2009 to bring its “Baby B” stock down from more than $3,000 a pop to a manageable amount under $100 per share. Did it change the company? Did Warren Buffett become any smarter or dumber as a result?
And on a more basic level, you make the same amount of money owning one share of a $3,000 stock as you do with 3,000 shares of a $1 stock. Either way, you have the same amount of money invested — it’s just divided up differently.
So if you’re afraid of high-priced stocks or in love with bargain picks, take a moment to consider these five stocks with $200-plus price tags — and the potential to move even higher in the months ahead:
5 $200-Plus Stocks Worth Every Cent to invest in 2013 - Intuitive Surgical (NASDAQ:ISRG) makes the innovative da Vinci surgical systems that have revolutionized operations used to treat cancer and heart disease, among other things. Without getting too technical, Intuitive Surgical gear allows doctors to operate on a patient with fewer incisions, speeding up recovery time and reducing the risk of complications. ISRG is up 400% in five years — taking the recession in stride thanks to powerful growth as its technology has caught on and as aging baby boomers create increased demand for surgeries. The company has seen nine straight quarters of year-over-year profit increases and has seen a streak of revenue increases even longer than that. Health care is one of the few growth areas in the American economy, and ISRG is well positioned to capitalize on this trend.
5 $200-Plus Stocks Worth Every Cent to invest in 2013 - Apple (NASDAQ:AAPL) is the $400 gorilla of Wall Street that dares you to bet against it. Yeah, shares dropped 15% from October to November — but Apple has bounced back in a big way, hitting an all-time high Wednesday, and seems ready to move even higher. The iPad 3 could come as recently as February, if you believe the rumors, and Apple clearly is looking to maintain its stranglehold on the tablet market. Wall Street is admittedly ga-ga for Apple, so you have to beware of the hype. Still, a forward price-to-earnings ratio of less than 11 hints that there still is time to buy Apple for the continued march upward.
5 $200-Plus Stocks Worth Every Cent to invest in 2013 - MasterCard (NYSE:MA) is at the center of a macro trend that is tough to ignore: the death of paper money. Per-swipe transactions continue to rise even in America, since as much as 40% of transactions in the U.S. still take place with cash or paper checks. But the real growth for MasterCard is coming from emerging markets, where a rising middle class is getting access to bank accounts and debit cards. Remember, MasterCard is not a debt issuer, but more of a toll-taker on the e-commerce superhighway. Every time you make a purchase, MasterCard gets paid — and it’s hard to believe that the number of people using plastic is going to decline anytime soon.
5 $200-Plus Stocks Worth Every Cent to invest in 2013 - Priceline (NASDAQ:PCLN) and its iconic pitchman William Shatner have taken over the travel business with an innovative “name your own price” model for airfares, hotels, rental cars and a host of other services. However, the real growth isn’t at home from people booking trips to Florida to see the grandparents — it’s internationally. PCLN offers hotel room reservations in about 100 countries and more than 40 languages. That has allowed for big growth despite the fact that Priceline is competing with internet travel sites like Kayak that have popped up in recent years. Profits are on track to double from 2010 to 2011, and grow an additional 25% in 2012.
5 $200-Plus Stocks Worth Every Cent to invest in 2013 - W.W. Grainger (NYSE:GWW) is a rather un-sexy company when compared to the others on this list. It is engaged in “facilities maintenance,” a glorified way to refer to distributing pumps, tools, motors and other gear that allow businesses to … well, do business. That might not sound exciting, but a 60% surge in GWW stock since the summer is worth taking note of. The company has seen eight consecutive quarters of year-over-year revenue increases. EPS numbers jumped 29% from 2010 to 2011 and are set to surge another 17% in 2012. W.W. Grainger is expanding in China and Panama, too, which could add even more momentum to shares. You might want to wait for a pullback after the red-hot run recently, however.

The 5 Best ETFs to Invest for 2013

Buying targeted dividend ETFs is easier than buying high-yield dividend stocks.
Dividend stocks were red-hot last year as the über-volatile market sent investors headlong into what has traditionally been the most stable segment of the equity universe. And while it isn’t likely we’ll see quite as much volatility in 2012 as we did in the final four months of 2011, powerful unknowns, such as Europe’s unresolved debt issues and China’s economic slowdown, could put real pressure on global economic growth — and by extension, the fate of the world’s equity markets. That means we could be in for an extended period of volatility and more capital inflows into the dividend space.
As investors, we can buy a well-thought-out group of solid, high-profile dividend stocks to gain exposure to the segment. But it’s easier to buy targeted dividend ETFs that already contain baskets of the best — and highest-yielding — dividend-paying securities.
The 5 Best ETFs to Invest for 2013 - iShares Dow Jones Select Dividend Index
The iShares Dow Jones Select Dividend (ETF) (NYSE:DVY) is an ETF pegged to the Dow Jones index bearing its name. This ETF really saw gains during the final three months of 2011, perhaps the most volatile time for stocks all last year. The fund surged 11% over that period, and that gain came with a 3.44% annual yield (as of Jan. 13). DVY counts among its top holdings such stellar corporate names as Lorillard (NYSE:LO), Chevron (NYSE:CVX), Kimberly-Clark (NYSE:KMB) and McDonald’s (NYSE:MCD), to name just a few. The fund’s expense ratio is only 0.40%, making the cost of owning these high-end performers very attractive.
SPDR S&P International Dividend
International stocks were by no means the best performers last year, but that didn’t stop the SPDR S&P International Dividend (ETF) (NYSE:DWX) from delivering a solid dividend yield of 4.02%. DWX’s expense ratio is 0.45%, just slightly higher than the domestic-equity focused DVY. For this modest cost, you get diversified exposure to international dividend stocks in income sectors such as telecommunications, utilities and financials.
The 5 Best ETFs to Invest for 2013 - WisdomTree Equity Income Fund
WisdomTree Equity Income Fund (NYSE:DHS) enjoyed a good year, and it performed particularly well in the final quarter. The fund is up almost 8% over the past three months, and that comes with an annual yield of 3.31%. Its holdings are based on WisdomTree’s Equity Income Index, which reads like a Who’s Who of dividend stalwarts. Companies such as AT&T (NYSE:T), General Electric (NYSE:GE), Johnson & Johnson (NYSE:JNJ) and Procter & Gamble (NYSE:PG) top the list of payout performers you get when you own DHS. And at an expense ratio of just 0.38%, you get these great companies on the cheap.
The 5 Best ETFs to Invest for 2013  - iShares S&P U.S. Preferred Stock Index Fund
The iShares S&P U.S. Preferred Stock Index Fund (NYSE:PFF) is an ETF that gives you exposure to preferred stocks. I like this fund primarily because of its outstanding 6.99% yield, but I also like it because it diversifies your income portfolio by owning the preferred shares of some of the world’s best companies. HSBC Holdings (NYSE:HBC), General Motors (NYSE:GM), Wells Fargo (NYSE:WFC) and many others have issued high-yield preferred shares, and the easiest and cheapest way to own these equities — at an expense ratio of just 0.48% — is to have PFF in your portfolio.
The 5 Best ETFs to Invest for 2013 - Claymore/Zacks Multi-Asset Income Index
Clamymore/Zacks Multi-Asset Income Index (ETF) (NYSE:CVY) is perhaps the most eclectic fund of my five best ETFs for 2012. CVY has had a great run over the past three months, vaulting nearly 6% while offering an annual yield of 5.42%. One huge reason to love CVY is that it contains a host of different types of high-yield securities. In addition to domestic and international stocks, the fund holds real estate investment trusts, master limited partnerships, closed-end funds, Canadian royalty trusts and traditional preferred stocks. Owning CVY gives you the best of the best when it comes to income securities at a quite acceptable 0.78% expense ratio

Top 5 Emerging Growth Stocks to Buy for January in 2012

If you have cash to invest this month, I highly recommend these five below. Here they are, in no particular order:
Taiwan-based Silicon Motion Technology (NASDAQ:SIMO) has its hand in lots of hot markets and is a big player in flash memory storage — flash memory cards, USB flash drives, card readers and solid-state hard drives. In fact, most of the NAND flash and next-generation flash products on the market — whether produced by Samsung (PINK:SSNLF), SanDisk (NASDAQ:SNDK), Toshiba, Micron (NASDAQ:MU) or Intel (NASDAQ:INTC) — are supported by Silicon Motion controllers. Silicon Motion also produces multimedia chips including embedded graphics processors, image processors and TV tuners. Lastly, it has been increasingly focused on controllers for smartphones, tablets and notebook PCs, as well as wireless transceivers for 4G LTE smartphones and tablets.
In the third quarter, Silicon Motion’s sales rose 25% to $63.2 million compared with $50.5 million in the second quarter. Looking forward, the analyst community is expecting annual fourth-quarter sales growth of 51% and 88.9% earnings growth. In the past three months, the analyst community has revised their consensus earnings estimate 32% higher — a phenomenon that typically precedes blowout earnings surprises.
Top 5 Emerging Growth Stocks to Buy for January in 2012 - Questor Pharmaceuticals (NASDAQ:QCOR) likes a challenge. As a specialist of difficult-to-treat central nervous system disorders, the company has been particularly successful with its multiple sclerosis treatment, H.P. Acthar Gel. The company also makes Doral, which is used for the treatment of insomnia. In the massive biotechnology industry, Questcor is top-notch in terms of earnings per share growth and return on equity.
For the fourth quarter, the analyst community is expecting 127.4% annual sales growth and 265.7% earnings growth of 38 cents per share. In the past three months, the analyst community has revised their consensus earnings estimate 32.6% higher. Typically, such positive analyst earnings revisions precede future earnings surprises.
Top 5 Emerging Growth Stocks to Buy for January in 2012 -Hansen Natural (NASDAQ:HANS) is the mastermind behind Monster, a dominant energy drink in the U.S. Looking at a can of Monster Energy drink, the flashy staple of sleep-deprived college students, one wouldn’t think that the company’s humble beginnings stem back to just one father and three sons working with a juicer in Southern California. In fact, although Hansen sells supercharged drinks like Monster and Java Monster, most of its drink roster is actually very wholesome. For example, it has 30 real fruit and spice soda flavors, a number of immune system-boosting drinks, vitamin waters and an array of teas and lemonades.
In recent quarters, Hansen Natural has reported “monster” sales and profit growth. Third-quarter sales jumped 24% from $381.5 million last year to $474.7 million this quarter. Over the same period, net income also rose 24% to $82.4 million, or 88 cents per share. Plus, speculation is heating up that Monster might be an acquisition target by Red Bull or one of the major soft drink companies. With Red Bull’s recent decision to pull out of NASCAR as a sponsor, a “monster” acquisition might be just what the energy drink maker needs to capture additional U.S. market share.
Top 5 Emerging Growth Stocks to Buy for January in 2012 - Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) is familiar pharmaceutical company I once discussed in the Top 5 Emerging Growth Stocks for December. Spectrum specializes in oncology — the treatment of cancer — and currently has two cancer treatments on the market: Fusilev, a treatment for advanced colon cancer, and Zevalin, a treatment for a type of lymphoma.
But what really excites me about this company is what it has in its pipeline: Spectrum has more than 10 drugs in either late-stage development or development! This includes Apaziquone, a treatment for bladder cancer, Belinostat, another lymphoma treatment and Ozarelix, a treatment of prostate cancer. This is a midsize biotechnology company already at the top of the industry — in terms of return on equity — and is about to experience blowout growth.
Top 5 Emerging Growth Stocks to Buy for January in 2012 - Jazz Pharmaceuticals Inc. (NASDAQ:JAZZ) has two flagship drugs — Xyrem, the only narcolepsy treatment approved by the World Anti-Doping Agency, and Luvox CR, its obsessive compulsive disorder treatment. But there are a number of exciting developments on the near horizon, including Jazz’s massive buyout of Dublin-based Azur Pharma Ltd., which should close within the next couple of weeks, and the company’s subsequent moving of its headquarters to Dublin. After the move, Jazz will be able to take advantage of Ireland’s competitive tax rate.
The company’s sales climbed 63.3% and earnings surged 115.6% in the third quarter, and for the fourth quarter, the analyst community is expecting 54% annual sales growth and 70.5% earnings growth. Jazz Pharmaceuticals is flush with cash and recently prepaid $33 million in long-term debt, and I’m excited to see how developments play out in the company’s next earnings release. Also, despite those who might think that Jazz Pharma’s bullish run looks tapped out, I remain optimistic.

Top 6 Stocks to Buy for February in 2012

With business inventories low, manufacturing up in December, an increase in housing starts in November, consumer confidence up, and the unemployment rate falling, the economy appears to be slowly improving. But global issues and especially problems in the EU still plague the market.
January started on a positive note with the Dow up over 3%, thus the familiar saying, “As goes the first week of the new year, so goes the month and so goes the year,” was frequently repeated. But on Jan. 26, the Dow and the S&P 500 executed “daily reversals,” and since then prices have been falling. All of our internal and sentiment indicators are overbought, and so the market could end the month on a negative yet still have delivered one of the most impressive bullish performances in years.
It is important for investors to focus on high-quality stocks that pay dividends and/or have a history of regular dividend increases. Some also have stock buyback programs in place to use part of their cash and reduce the number of shares trading. Both strategies should have a positive long-term impact on the companies’ stocks.
Here are your top stocks to buy for February:

Top Stock to Buy #1 – Barrick Gold Corp. (ABX)

Barrick Gold Corp. (NYSE:ABX), an acquirer, explorer and developer of gold, copper, silver and zinc, is charted using monthly rather than daily data. This long-term chart clearly shows a bullish cup-and-handle formation. But for the stock to break out it must close above $55. If ABX breaks $55, look for a major rally to $75 to $80.
Earnings are estimated at $4.94 in 2011 and $5.58 in 2012. The dividend yield is 1.21%. This stock is rated a “five-star strong buy” by S&P with a 12-month target of $80.

Top Stock to Buy #2 – Chevron Corp. (CVX)

Chevron Corp. (NYSE:CVX) primarily engages in exploration, refining, transportation and storage of crude oil and natural gas. The stock has formed a neckline at $110 after establishing a double-bottom. The overall pattern is an inverse head-and-shoulders — a very bullish development. All that is required to trigger a strong buy is for the stock to close above the neckline. This is a huge bullish formation with a technical target of $132.
S&P has CVX rated a “five-star strong buy” with a target of $132. The consensus estimated earnings for 2011 are $14.02 and $13.65 for 2012. The annual dividend is $3.24, providing a yield of 3.12%. The company is expected to continue to increase dividends and is executing a share buyback program.
Top Stock to Buy #3 – H.J. Heinz Co. (HNZ)
H.J. Heinz Co. (NYSE:HNZ), a producer of a wide variety of food products, has a new, more aggressive corporate strategy. Acquisitions in “emerging markets” began two years ago, and in 2011 that new direction accounted for 16% of total sales. Earnings for FY 2011 were $3.06 and are estimated to be $3.30 in FY 2012. HNZ has a dividend yield of 3.71% and a history of increasing dividends. The fundamental target for HNZ is $60.
Technically the stock has double-bottomed at $48 and formed a neckline of resistance at $54.50. A recent buy signal from our proprietary indicator, the Collins-Bollinger Reversal (CBR), tells us to buy now for a breakout and run to $62.

Top Stock to Buy #4 – United Health Group (UNH)

The diversified United Health Group (NYSE:UNH) provides health care programs and retirement plans, has a life sciences group, and provides health plans to physicians, clinical services, etc.
Credit Suisse analysts consider UNH to be the best-positioned company in its field and look for earnings of $4.85 this year compared to $4.73 in 2011, and an increase to $5.60 in 2013. UNH has a dividend yield of 1.27%.
Technically the stock has consolidated in a broad cup. A break through $54 should produce a trading target of $62.
Top Stock to Buy #5 – Verizon Communications (VZ)
Verizon Communications’ (NYSE:VZ) earnings are expected to grow to $2.50 next year, up from $2.23 in 2011, and strong operating margins and network quality are expected to attract customers to its 3G and 4G networks.
The communications sector has been one of the strongest in the closing months of 2011, and VZ has been a leader of the group. But the sector, and Verizon, may have run too far too fast. An increase in sellers and a short-term sell signal from its stochastic warn that a correction is likely.
Buy VZ on a pullback under $38 for a longer-term advance to the mid-$40s.
Top Stock to Buy #6 – Whole Foods Market (WFM)
Whole Foods Market (NASDAQ:WFM), the operator of the largest chain of natural food supermarkets in theUnited States, appears headed to new highs. Sales are expected to increase by 15% in 2012, and earnings are estimated to increase to $2.27 from $1.93 in 2011 and $1.43 in 2010. The adoption of a new price strategy, more lower-priced offerings, and an expansion plan are expected to lead to better-than-average industry growth. The dividend will likely be increased from the current 56 cents per share, and the repurchase of shares is expected.
Technically WFM has been in a powerful bull channel for over a year, and while there is no reason to expect a change, the stock is currently in a correction and will most likely hold at the lower support line of the channel at the 50-day moving average at $70 where it should be bought. The target for a trade is $80 by the end of March. Longer-term buyers should expect continued growth and higher prices.

3 Undervalued Tech Stocks to Buy in 2012

When investors see the words “undervalued tech stocks,” the first companies that jump to mind are probably the mega-cap giants like Cisco (NASDAQ:CSCO) and Microsoft (NASDAQ:MSFT). The large-cap space certainly has more than its share of cheap tech stocks, but a look into mid- and small-cap territory reveals other, less talked-about opportunities. Computer Sciences (NYSE:CSC), Lexmark International (NYSE:LXK), and China Digital TV (NYSE:STV), are three such stocks that deserve more attention than they receive.
3 Undervalued Tech Stocks to Buy in 2012 - Computer Sciences
Shares of CSC, an IT-outsourcing company, have been pummeled from a February high above $56 to $37.20 on Wednesday. The stock has been hit by less-than-stellar earnings results and concerns that the U.S. government’s perilous fiscal situation will weigh on the 39% of CSC’s business that comes from federal contracts. That’s undoubtedly a legitimate worry, but also one that is well-known at this point. At 7.3 times 2012 estimates (and a price-to-earnings-to-growth ratio of 0.9) and a share price sitting at 0.8 times book value, it appears that the bad news is fully discounted in the stock. Two other key points regarding CSC: first, the stock yields 2.2% – much better than you’ll find with the average large-cap tech stock. Second, the company is cash-rich and is frequently mentioned as a target of a buyout. Betting on a takeover is always a dicey proposition, but CSC offers investors a solid risk-reward tradeoff even without the benefit of a buyout.
Keep in mind: The last time CSC’s P/E was at this level, the stock traded up 25% in less than two months.
3 Undervalued Tech Stocks to Buy in 2012 - Lexmark International
A maker of printers, ink, and imaging products, Lexmark has seen its shares come under heavy selling pressure since late 2010 – a trend that wasn’t helped by its May earnings miss. While the printing business is indeed in gradual decline, it may finally be time to say “enough is enough” regarding the downturn in Lexmark’s share price. After hitting a high above $47 in mid-October, the stock now stands at $28.62. At this level, the stock trades at forward P/E of less than 7x, and removing the net cash of $7 a share (about a quarter of its market cap) on its balance sheet brings the P/E below 5.5x. A low P/E can be a trap when growth is slowing, of course, but the company’s core ink business continues to generate substantial free cash flow. And like CSC, Lexmark has the added benefit of being a strong candidate for an eventual takeover.
Keep in mind: The recent selloff has driven LXK’s valuation to its lowest level in history.
3 Undervalued Tech Stocks to Buy in 2012 - China Digital TV
The smallest of the three companies discussed here, China Digital could offer big potential to patient investors. The company makes smart cards that allow the conversion of an analog signal to digital. A boring business perhaps, but consider that China is the world’s largest TV market with 377 million viewing households. Of these, 187 million have cable and only 90 million currently have a digital signal. This adds up to a stellar growth opportunity for a company with no debt and over 70% of its market cap accounted for by the $214 million of cash on its balance sheet. The stock trades for less than 7x 2012 earnings estimates and a PEG of just over 0.4. Chinese stocks are not without risk, as 2011 has taught us, but patient investors who tune into STV may be in for quite a show.

Keep in Mind: Like LXK, CSC trades at an all-time low P/E.
Technology investing has been no picnic for investors thus far in 2011, but these stocks provide a compelling margin of safety in the event of further volatility in the months ahead.

Best Stocks to buy 2012 Labels